These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24614632)

  • 21. Neuroprotective effects of a Rhodiola crenulata extract on amyloid-β peptides (Aβ
    Zhang X; Wang X; Hu X; Chu X; Li X; Han F
    Phytomedicine; 2019 Apr; 57():331-338. PubMed ID: 30807987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Icariin improves memory impairment in Alzheimer's disease model mice (5xFAD) and attenuates amyloid β-induced neurite atrophy.
    Urano T; Tohda C
    Phytother Res; 2010 Nov; 24(11):1658-63. PubMed ID: 21031624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Endoplasmic Reticulum Stress in Learning and Memory Impairment and Alzheimer's Disease-Like Neuropathology in the PS19 and APP
    Briggs DI; Defensor E; Memar Ardestani P; Yi B; Halpain M; Seabrook G; Shamloo M
    eNeuro; 2017; 4(4):. PubMed ID: 28721361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study on establishment of Alzheimer's disease animal model and intervening effect of zhinao capsule on it].
    Han MX; Yang WM; Li ZG
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Sep; 23(9):688-91. PubMed ID: 14571619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
    Kashiwa Y; Kitabayashi Y; Narumoto J; Nakamura K; Ueda H; Fukui K
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotection, learning and memory improvement of a standardized extract from Renshen Shouwu against neuronal injury and vascular dementia in rats with brain ischemia.
    Wan L; Cheng Y; Luo Z; Guo H; Zhao W; Gu Q; Yang X; Xu J; Bei W; Guo J
    J Ethnopharmacol; 2015 May; 165():118-26. PubMed ID: 25704930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice.
    Hayashi Y; Ishida Y; Inoue T; Udagawa M; Takeuchi K; Yoshimuta H; Kiue K; Ninomiya Y; Kawano J; Sameshima T; Kawahara T; Goto I; Shudo K; Kurayama S; Nakamura J; Okahara K; Mitsuyama Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):541-5. PubMed ID: 20184936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
    Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
    J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New possibility of traditional Chinese and Japanese medicine as treatment for behavioral and psychiatric symptoms in dementia.
    Kung FC; Ishii R; Liu HC; Takeda M
    Clin Interv Aging; 2012; 7():393-6. PubMed ID: 23055705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revalidation of the neuroprotective effects of a United States patented polyherbal formulation on scopolamine induced learning and memory impairment in rats.
    Upadhyay P; Sadhu A; Singh PK; Agrawal A; Ilango K; Purohit S; Dubey GP
    Biomed Pharmacother; 2018 Jan; 97():1046-1052. PubMed ID: 29136783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycyrrhiza and Uncaria Hook contribute to protective effect of traditional Japanese medicine yokukansan against amyloid β oligomer-induced neuronal death.
    Kanno H; Kawakami Z; Iizuka S; Tabuchi M; Mizoguchi K; Ikarashi Y; Kase Y
    J Ethnopharmacol; 2013 Aug; 149(1):360-70. PubMed ID: 23838475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective effects of Tongmai Yizhi Decoction () against Alzheimer's disease through attenuating cyclin-dependent kinase-5 expression.
    Feng JH; Cai BC; Guo WF; Wang MY; Ma Y; Lu QX
    Chin J Integr Med; 2017 Feb; 23(2):132-137. PubMed ID: 27392479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ameliorative effect of traditional Japanese medicine yokukansan on age-related impairments of working memory and reversal learning in rats.
    Mizoguchi K; Shoji H; Tanaka Y; Tabira T
    Neuroscience; 2011 Mar; 177():127-37. PubMed ID: 21195139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yokukansan Ameliorates Hippocampus-Dependent Learning Impairment in Senescence-Accelerated Mouse.
    Azuma K; Toyama T; Katano M; Kajimoto K; Hayashi S; Suzuki A; Tsugane H; Iinuma M; Kubo KY
    Biol Pharm Bull; 2018; 41(10):1593-1599. PubMed ID: 30270329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paroxetine administration decreases AD-like pathology and reverses memory impairments in a transgenic model of Alzheimer disease.
    Bales KR
    Exp Neurol; 2007 Sep; 207(1):1-3. PubMed ID: 17662278
    [No Abstract]   [Full Text] [Related]  

  • 36. Ameliorative effects of telmisartan on the inflammatory response and impaired spatial memory in a rat model of Alzheimer's disease incorporating additional cerebrovascular disease factors.
    Shindo T; Takasaki K; Uchida K; Onimura R; Kubota K; Uchida N; Irie K; Katsurabayashi S; Mishima K; Nishimura R; Fujiwara M; Iwasaki K
    Biol Pharm Bull; 2012; 35(12):2141-7. PubMed ID: 23207766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological treatment of behavioural and psychological symptoms of dementia in psychogeriatric inpatient units.
    Restifo S; Lemon V; Waters F
    Australas Psychiatry; 2011 Feb; 19(1):59-63. PubMed ID: 21189108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zotepine for behavioural and psychological symptoms in dementia: an open-label study.
    Rainer MK; Krüger-Rainer C; Haushofer M; Mucke HA
    CNS Drugs; 2004; 18(15):1165. PubMed ID: 15581386
    [No Abstract]   [Full Text] [Related]  

  • 39. The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial.
    van Dongen MC; van Rossum E; Kessels AG; Sielhorst HJ; Knipschild PG
    J Am Geriatr Soc; 2000 Oct; 48(10):1183-94. PubMed ID: 11037003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clarifying evidence of pharmacological effects of Kampo medicine].
    Iwasaki K
    Nihon Yakurigaku Zasshi; 2014 Feb; 143(2):53-4. PubMed ID: 24761471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.